维普期刊资源整合服务平台（V6.5）

54篇 您的检索式：作者名="Jayson C"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Ovarian cancer 显示文摘	JAYSON G C KOHN E C KITCHENER H C	2014	Lancet2014，384，9951：	1
2	Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer显示文摘	Jayson GC Mulatero C Ranson M	2005	Eur J Cancer2005，41，4：	1
3	Angiogenesis as a target for the treatment of ovarian cancer显示文摘	SHAW D CLAMP A JAYSON G C	2013	Curr Opin Oncol2013，25，5：	1
4	Phase m randomized trial of docetaxel- carboplatin versus paclitaxel -earboplatin as first line chemotherapy for ovarian carcinoma显示文摘	Vasey P A Jayson G C Gordon A	2004	J Natl Cancer Inst2004，96，22：	1
5	Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma显示文摘	Jackson A Jayson G C Li K L	2003	Br J Radiol2003，76，903：	1
6	Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer显示文摘	Jayson GC Mulatero C Ranson M	2005	Eur J Cancer2005，41，4：	1
7	Analysis of blood plasma factors in the AVITA Phase III randomized study of bevacizumab (bey) with gemcitabine - erlotinib ( GE ) in pa- tients(pts ) with metastatic pancreatic cancer (mPC) 显示文摘	Van Cutsem E Jayson G Dive C	2011	European Muhidisciplinary Cancer Congress Stockholm2011，，9：	1
8	Risk Perceptions,Risk Preference,and Acceptance of Risky Food显示文摘	Jayson L L Keith H C	2005	American Journal of Agricultural Economics2005，87，2：	1
9	Differential body weight and feeding responses to high-fat diets in rats and mice lacking cholecystokinin 1 receptors显示文摘	SHENG B JIE C JAYSON H	2007	American Journal of Physiology Regulatory: Intergrative and Comparative Physiology2007，293，4：	1
10	The current and future management of malignant ascites显示文摘	SMITH E M JAYSON G C	2003	Clinical Oncology(Royal College of Radiologists(Great Britain))2003，15，2：	1
11	Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, pegylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volume显示文摘	Jayson G C Parker G J Mullamitha S	2005	J Clin Oncol2005，23，97：	1
12	Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue显示文摘	Wardley A M Jayson G C Swindell R	2000	Br J Haematol2000，110，2：	1
13	The current and future management of malignant ascites 显示文摘	SMITH E M JAYSON G C	2003	Clin Oncol2003，15，：	1
14	The current and future management of malig- nant ascites显示文摘	Smith E M Jayson G C	2003	Cin Oncol (R Coil Radiol)2003，15，2：	1
15	A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis 显示文摘	Baka S Clamp A R Jayson G C	2006	Expert Opin Ther Targets2006，，10：	1
16	The clinical development of the brystatins显示文摘	Clamp A Jayson G C	2002	Anticancer Drugs2002，13，：	1
17	Phase Ⅰ investigation of recombinant anti-human vascular endotheli al growth factor antibody in patients with advanced cancer显示文摘	JAYSON G C MULATERO C RANSON M	2005	EurJ Cancer2005，41，4：	1
18	Biomarkers of angiogenesis and their role in the development of VEGF inhibitors 显示文摘	Murukesh N Dive C Jayson GC	2010	Br J Cancer2010，102，1：	1
19	The clinical development of the bryostatins显示文摘	Clamp A Jayson G C	2002	Anticancer Drugs2002，13，7：	1
20	Ovarian cancer显示文摘	Gordon C Jayson Elise C Kohn Henry C Kitchener Jonathan A Ledermann	2014	The Lancet2014，，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示